Detecting drug-drug interactions between therapies for COVID-19 and concomitant medications through the FDA adverse event reporting system is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5T15LM007450-18
Vanderbilt Biomedical Informatics Training Program
National Institutes of Health
Grant: 5R01LM012854-03
Discovering Care Coordination Practice Patterns in the EMR: Interpretation and Impact on Patient Outcomes
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals